Insider · CIK 0001883766

Barnett Eva Renee

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001883766

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-16	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,993 sh	$14.89	−$44.6K	396,774
2025-04-09	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−7,013 sh	$12.99	−$91.1K	403,817
2025-04-09	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,050 sh	$12.99	−$52.6K	399,767
2025-04-01	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+88.9K sh	—	—	410,830
2025-04-01	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,180
2025-02-19	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,814 sh	$20.86	−$58.7K	321,952
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−109 sh	$24.19	−$2,636.71	324,766
2025-01-15	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,189 sh	$23.81	−$52.1K	324,875
2025-01-08	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,105 sh	$24.10	−$98.9K	327,064
2024-11-20	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,174 sh	$25.45	−$106K	331,169
2024-10-16	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−3,271 sh	$28.79	−$94.2K	335,343
2024-10-09	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−5,162 sh	$29.56	−$153K	338,614
2024-08-21	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−149 sh	$32.32	−$4,815.68	343,776
2024-08-21	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−3,619 sh	$31.84	−$115K	343,925
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,939 sh	$29.64	−$87.1K	347,728
2024-07-17	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−184 sh	$30.55	−$5,621.2	347,544
2024-07-09	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,747 sh	$28.06	−$133K	350,667
2024-05-22	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,042 sh	$29.65	−$120K	355,414
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,774 sh	$29.94	−$83.1K	359,456
2024-04-17	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−9,479 sh	$28.80	−$273K	362,230
2024-04-09	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−3,689 sh	$31.18	−$115K	371,709
2024-04-02	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+55K sh	—	—	375,398
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+68.7K sh	—	—	68,723
2024-02-22	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,930 sh	$36.15	−$106K	320,420
2024-01-11	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−834 sh	$42.43	−$35.4K	323,350
2024-01-11	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,681 sh	$41.64	−$112K	324,184
2023-11-22	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−3,901 sh	$32.75	−$128K	327,019
2023-11-22	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−154 sh	$33.52	−$5,162.08	326,865
2023-10-10	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,557 sh	$36.92	−$168K	330,920
2023-08-24	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−14.4K sh	$20.30	−$292K	335,478
2023-08-24	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−1 sh	$20.89	−$20.89	335,477
2023-07-19	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−2,725 sh	$24.94	−$68K	349,863
2023-04-18	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−3,423 sh	$15.27	−$52.3K	352,588
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+114K sh	—	—	113,821
2023-04-12	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+87.7K sh	—	—	356,011
2023-01-11	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−11 sh	$15.15	−$166.65	272,846
2023-01-11	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−4,499 sh	$16.75	−$75.4K	268,347
2022-10-11	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−12.5K sh	$9.44	−$118K	272,857
2022-08-17	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+113K sh	—	—	285,357
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+170K sh	—	—	169,648
2022-01-07	IMVTImmunovant, Inc.S Sale	Chief Financial Officer	SSale	−30K sh	$7.25	−$217K	172,541
2021-10-15	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+333K sh	—	—	333,000
2021-10-15	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+143K sh	—	—	202,500
2021-10-04	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+59.5K sh	—	—	59,500

Recent filings

Accepted (ET)
Apr 174
Barnett Eva Renee0001764013-25-000076
SEC(opens sec.gov)
Apr 114
Barnett Eva Renee0001764013-25-000067
SEC(opens sec.gov)
Apr 34
Barnett Eva Renee0001764013-25-000051
SEC(opens sec.gov)
Feb 214
Barnett Eva Renee0001764013-25-000031
SEC(opens sec.gov)
Jan 174
Barnett Eva Renee0001764013-25-000014
SEC(opens sec.gov)
Jan 104
Barnett Eva Renee0001764013-25-000004
SEC(opens sec.gov)
Nov 224
Barnett Eva Renee0001764013-24-000194
SEC(opens sec.gov)
Oct 184
Barnett Eva Renee0001764013-24-000171
SEC(opens sec.gov)
Oct 114
Barnett Eva Renee0001764013-24-000166
SEC(opens sec.gov)
Aug 234
Barnett Eva Renee0001764013-24-000158
SEC(opens sec.gov)
Jul 194
Barnett Eva Renee0001764013-24-000135
SEC(opens sec.gov)
Jul 104
Barnett Eva Renee0001764013-24-000127
SEC(opens sec.gov)
May 244
Barnett Eva Renee0001764013-24-000099
SEC(opens sec.gov)
Apr 194
Barnett Eva Renee0001764013-24-000079
SEC(opens sec.gov)

Companies

Immunovant, Inc.Chief Financial OfficerIMVT

Address

C/O IMMUNOVANT, INC. 320 W 37TH STREET, 6TH FLOOR

NEW YORK, NY, 10018